These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 30833102)
1. Comparison of classical transrectal prostate biopsy versus cognitive registration in rebiopsy. Barbas Bernardos G; Herranz Amo F; de Miguel Campos E; Luis Cardo A; Herranz Arriero A; Cancho Gil MJ; Caño Velasco J; Jara Rascón J; Mayor de Castro J; Hernández Fernández C Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):228-233. PubMed ID: 30833102 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the «cognitive» biopsy in the diagnosis of prostate cancer in patients with a previous negative biopsy. Barbas Bernardos G; Herranz Amo F; de Miguel Campos E; Luis Cardo A; Herranz Arriero A; Caño Velasco J; Cancho Gil MJ; Jara Rascón J; Mayor de Castro J; Hernández Fernández C Actas Urol Esp (Engl Ed); 2019; 43(1):12-17. PubMed ID: 30131167 [TBL] [Abstract][Full Text] [Related]
3. A Prospective Comparison of Transrectal Standard, Cognitive, Transperineal Fusion, and Mapping Prostate Biopsy for Cancer Detection. Petov V; Bazarkin A; Morozov A; Taratkin M; Ganzha T; Danilov S; Chernov Y; Chinenov D; Rzayev R; Suvorov A; Amosov A; Fajkovic H; Enikeev D; Krupinov G J Endourol; 2023 Aug; 37(8):940-947. PubMed ID: 37294206 [No Abstract] [Full Text] [Related]
4. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies. Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy. Lim CS; Abreu-Gomez J; Carrion I; Schieda N AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208 [No Abstract] [Full Text] [Related]
6. MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort. Luzzago S; de Cobelli O; Mistretta FA; Piccinelli ML; Lorusso V; Morelli M; Bianchi R; Catellani M; Cozzi G; Di Trapani E; Pricolo P; Alessi S; Ferro M; Marvaso G; Matei DV; Jereczek-Fossa BA; Petralia G; Musi G Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):406-413. PubMed ID: 32989259 [TBL] [Abstract][Full Text] [Related]
7. "In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation. Porreca A; D'Agostino D; Vigo M; Corsi P; Romagnoli D; Del Rosso A; Schiavina R; Brunocilla E; Artibani W; Giampaoli M Arch Ital Urol Androl; 2020 Jan; 91(4):224-229. PubMed ID: 31937084 [TBL] [Abstract][Full Text] [Related]
8. Can preoperative multiparametric MRI avoid unnecessary prostate biopsies before holmium laser enucleation of the prostate? Preliminary results of a multicentric cohort of patients. Giampaoli M; Bianchi L; D'agostino D; Corsi P; Romagnoli D; Mineo Bianchi F; Del Rosso A; Schiavina R; Brunocilla E; Artibani W; Porreca A Minerva Urol Nefrol; 2019 Oct; 71(5):524-530. PubMed ID: 31166103 [TBL] [Abstract][Full Text] [Related]
9. Cognitive versus Software-Assisted Registration: Development of a New Nomogram Predicting Prostate Cancer at MRI-Targeted Biopsies. Kaufmann S; Russo GI; Thaiss W; Notohamiprodjo M; Bamberg F; Bedke J; Morgia G; Nikolaou K; Stenzl A; Kruck S Clin Genitourin Cancer; 2018 Aug; 16(4):e953-e960. PubMed ID: 29685613 [TBL] [Abstract][Full Text] [Related]
10. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique? Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655 [TBL] [Abstract][Full Text] [Related]
11. The addition of a sagittal image fusion improves the prostate cancer detection in a sensor-based MRI /ultrasound fusion guided targeted biopsy. Günzel K; Cash H; Buckendahl J; Königbauer M; Asbach P; Haas M; Neymeyer J; Hinz S; Miller K; Kempkensteffen C BMC Urol; 2017 Jan; 17(1):7. PubMed ID: 28086856 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure. Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851 [TBL] [Abstract][Full Text] [Related]
13. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen. Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370 [TBL] [Abstract][Full Text] [Related]
14. Central zone lesions on magnetic resonance imaging: Should we be concerned? Tan WP; Mazzone A; Shors S; Antoine N; Ekbal S; Khare N; McKiel C; Pessis D; Deane L Urol Oncol; 2017 Jan; 35(1):31.e7-31.e12. PubMed ID: 27692837 [TBL] [Abstract][Full Text] [Related]
15. Multiparametric magnetic resonance imaging predicts the presence of prostate cancer in patients with negative prostate biopsy. Lista F; Castillo E; Gimbernat H; Rodríguez-Barbero JM; Panizo J; Angulo JC Actas Urol Esp; 2015 Mar; 39(2):85-91. PubMed ID: 25267460 [TBL] [Abstract][Full Text] [Related]
16. Transrectal ultrasound-guided targeted biopsy of transition zone prostate cancer under cognitive registration with prebiopsy MRI and sonographic findings. Won SY; Cho NH; Choi YD; Park SY Clin Radiol; 2020 Feb; 75(2):157.e21-157.e27. PubMed ID: 31677880 [TBL] [Abstract][Full Text] [Related]
17. Cognitive fusion-targeted biopsy versus transrectal ultrasonography-guided systematic biopsy: comparison and analysis of the risk of Gleason score upgrading. Zheng T; Bi K; Tang Y; Zeng Y; Wang J; Yan L Int Urol Nephrol; 2024 Mar; 56(3):981-988. PubMed ID: 37875704 [TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology. Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS Acta Radiol; 2018 Mar; 59(3):371-380. PubMed ID: 28679325 [TBL] [Abstract][Full Text] [Related]
19. Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies. Maxeiner A; Nest AM; Stephan C; Cash H; Baur ADJ; Fischer T; Kilic E; Piper SK; Nowak CP; Busch J; Miller K; Mang J Urol Int; 2020; 104(3-4):205-213. PubMed ID: 31801153 [TBL] [Abstract][Full Text] [Related]
20. Cognitive MRI-TRUS fusion-targeted prostate biopsy according to PI-RADS classification in patients with prior negative systematic biopsy results. Lai WJ; Wang HK; Liu HT; Park BK; Shen SH; Lin TP; Chung HJ; Huang YH; Chang YH J Chin Med Assoc; 2016 Nov; 79(11):618-624. PubMed ID: 27567440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]